139 related articles for article (PubMed ID: 3137875)
21. Enhancement by hydrazine sulfate of antitumor effectiveness of cytoxan, mitomycin C, methotrexate and bleomycin, in walker 256 carcinosarcoma in rats.
Gold J
Oncology; 1975; 31(1):44-53. PubMed ID: 51492
[TBL] [Abstract][Full Text] [Related]
22. [Enhancement of anti-tumor effect of adriamycin by verapamil in a intrahepatic arterial infusion in the rats].
Shimoda T; Miyazaki M; Utagawa I; Koshikawa H; Ito H; Okui K
Nihon Geka Gakkai Zasshi; 1992 May; 93(5):481-7. PubMed ID: 1614393
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of the cytocidal effect of mitomycin C by means of simultaneous administration of prostaglandin E1.
Ichihashi H; Kuzuya H; Kondo T
Gan; 1983 Feb; 74(1):169-75. PubMed ID: 6404685
[TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of tumor necrosis factor alpha conjugated with divinyl ether and maleic anhydride copolymer on solid tumors in mice.
Kaneda Y; Yamamoto Y; Kamada H; Tsunoda S; Tsutsumi Y; Hirano T; Mayumi T
Cancer Res; 1998 Jan; 58(2):290-5. PubMed ID: 9443407
[TBL] [Abstract][Full Text] [Related]
25. Synergism of tumor necrosis factor-alpha and melphalan in systemic and regional administration: animal study.
Gutman M; Sofer D; Lev-Chelouche D; Merimsky O; Klausner JM
Invasion Metastasis; 1997; 17(4):169-75. PubMed ID: 9778589
[TBL] [Abstract][Full Text] [Related]
26. The effect of Arnebia nobilis and its naphthaquinones in rat Walker carcinosarcoma 256.
Gupta SK; Mathur IS
Indian J Cancer; 1972 Mar; 9(1):50-5. PubMed ID: 5044709
[No Abstract] [Full Text] [Related]
27. Oral activity of mitomycin C (NSC-26980) on Walker 256 (intramuscular) tumor.
Bradner WT
Cancer Chemother Rep; 1968 Apr; 52(3):389-91. PubMed ID: 5670720
[No Abstract] [Full Text] [Related]
28. Combination antitumor therapy with rabbit tumor necrosis factor and chemo- and immuno-therapeutic agents against murine tumors.
Gatanaga T; Takahashi K; Yamazaki M; Mizuno D; Abe S
Jpn J Cancer Res; 1985 Jul; 76(7):631-6. PubMed ID: 3928560
[TBL] [Abstract][Full Text] [Related]
29. [Repeated intra-arterial chemotherapy combined with mitomycin C and degradable starch microspheres in inoperable metastatic hepatic cancer].
Koike S; Fujimoto S; Guhji M; Endoh F; Shrestha RD; Kokubun M; Kobayashi K; Kiuchi S; Ooi T; Okui K
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2601-5. PubMed ID: 3137882
[TBL] [Abstract][Full Text] [Related]
30. Toxicity and pathological effects of a new dosage form of mitomycin C for carcinomatous peritonitis.
Hagiwara A; Takahashi T; Ueda T; Lee R; Takeda M; Itoh T
Anticancer Res; 1987; 7(1):105-8. PubMed ID: 3105418
[TBL] [Abstract][Full Text] [Related]
31. [Study on the antineoplastic agent "Mitomycin C" by the intra-arterial infusion method to the extremities].
Yoshizumi M
Nihon Geka Hokan; 1967 May; 36(3):334-54. PubMed ID: 5275453
[No Abstract] [Full Text] [Related]
32. Antitumor activity and toxicity in animals of BMY-25282, a new mitomycin derivative.
Bradner WT; Rose WC; Schurig JE; Florczyk AP; Huftalen JB; Catino JJ
Cancer Res; 1985 Dec; 45(12 Pt 1):6475-81. PubMed ID: 3933826
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions.
Inagawa H; Nishizawa T; Honda T; Nakamoto T; Takagi K; Soma G
Anticancer Res; 1998; 18(5D):3957-64. PubMed ID: 9854510
[TBL] [Abstract][Full Text] [Related]
34. [Circadian chronotherapy for Walker-256 of Wistar rat].
Sato T
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2287-90. PubMed ID: 7944461
[TBL] [Abstract][Full Text] [Related]
35. Effects of intra-arterially infused biodegradable microspheres containing mitomycin C.
Fujimoto S; Miyazaki M; Endoh F; Takahashi O; Shrestha RD; Okui K; Morimoto Y; Terao K
Cancer; 1985 Feb; 55(3):522-6. PubMed ID: 3917365
[TBL] [Abstract][Full Text] [Related]
36. Effect of mitomycin-C on recurrence and metastasis after the resection of experimental cecal tumor in rats.
Shiba S; Fujita M; Nakanishi K
Gan; 1966 Apr; 57(2):123-32. PubMed ID: 5959696
[No Abstract] [Full Text] [Related]
37. [Antitumor activity of CPT-11 against rat Walker 256 carcinoma].
Furuta T; Yokokura T; Mutai M
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2757-60. PubMed ID: 3415271
[TBL] [Abstract][Full Text] [Related]
38. [Studies on biodegradable microspheres containing mitomycin C].
Fujimoto S; Endoh F; Kitsukawa Y; Morimoto Y; Sugibayashi K; Okui K
Gan To Kagaku Ryoho; 1983 May; 10(5):1328-33. PubMed ID: 6409003
[TBL] [Abstract][Full Text] [Related]
39. Molecular design of hybrid tumor necrosis factor-alpha III: polyethylene glycol-modified tumor necrosis factor-alpha has markedly enhanced antitumor potency due to longer plasma half-life and higher tumor accumulation.
Tsutsumi Y; Kihira T; Tsunoda S; Kamada H; Nakagawa S; Kaneda Y; Kanamori T; Mayumi T
J Pharmacol Exp Ther; 1996 Sep; 278(3):1006-11. PubMed ID: 8819479
[TBL] [Abstract][Full Text] [Related]
40. Amplification of the antitumor activity of phleomycins and bleomycins in rats and mice by caffeine.
Allen TE; Aliano NA; Cowan RJ; Grigg GW; Hart NK; Lamberton JA; Lane A
Cancer Res; 1985 Jun; 45(6):2516-21. PubMed ID: 2580623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
